The utilization of recent advances in molecular and genomic technologies an
d progress in pancreatic imaging techniques provided remarkable insight int
o genetic, environmental, immunologic, and pathobiological factors leading
to chronic pancreatitis. Translation of these advances into clinical practi
ce demands a reassessment of current approaches to diagnosis, classificatio
n, and staging, We conclude that an adequate pancreatic biopsy must be the
gold standard against which all diagnostic approaches are judged, Although
computed tomography remains the initial test of choice for the diagnosis of
chronic pancreatitis, the roles of endoscopic retrograde pancreatography,
endoscopic ultrasonography, and magnetic resonance imaging are considered.
Once chronic pancreatitis is diagnosed, proper classification becomes impor
tant. Major predisposing risk factors to chronic pancreatitis may be catego
rized as either (1) toxic-metabolic, (2) idiopathic, (3) genetic, (4) autoi
mmune, (5) recurrent and severe acute pancreatitis, or (6) obstructive (TIG
AR-O system), After classification, staging of pancreatic function, injury,
and fibrosis becomes the next major concern, Further research is needed to
determine the clinical and natural history of chronic pancreatitis develop
ing in the context of various risk factors. New methods are needed for earl
y diagnosis of chronic pancreatitis, and new therapies are needed to determ
ine whether interventions will delay or prevent the progression of the irre
versible damage characterizing end-stage chronic pancreatitis.